Home >> Tag Archives: Oxford Gene Technology

Tag Archives: Oxford Gene Technology

OGT partners with Applied Spectral Imaging

July 2023—OGT, a Sysmex Group company, announced a commercial partnership with Applied Spectral Imaging. The agreement will grant OGT rights to market ASI’s proprietary cytogenetic imaging and analysis solutions in Great Britain, establishing a strategic partnership that the companies say combines the strengths of OGT’s CytoCell FISH portfolio with ASI’s imaging and analysis capabilities.

Read More »

OGT’s CytoSure v3 improves reporting rate

October 2020—According to a recent NPJ Genomic Medicine paper (Jezkova J, et al. 2020;5:28), Oxford Gene Technology’s CytoSure Constitutional v3 array design significantly improved reporting rate and proved to be a powerful tool for the detection of small pathogenic intragenic deletions and duplications in developmental disorder research. The paper was led by a consortium of National Health Service genomic medicine centers in the U.K.; it compared the enhanced exon-level gene coverage of the v3 array with a conventional array design.

Read More »

OGT’s CytoSure v3 improves reporting rate

July 27, 2020—In a recent NPJ Genomic Medicine paper, Oxford Gene Technology’s CytoSure Constitutional v3 array design has been shown to significantly improve reporting rate and been proven as a powerful tool for detection of small pathogenic intragenic deletions and duplications in developmental disorder research.

Read More »

CytoSure constitutional NGS panel

January 2020—Oxford Gene Technology has developed the CytoSure NGS panel for the detection of loss of heterozygosity, mosaicism, copy number variants, single nucleotide variants, and indels. The solution features up-to-date content for intellectual disability and developmental delay, the targeted NGS panel, and Interpret software.

Read More »

OGT expands sales support in Europe

October 2018—Oxford Gene Technology announced it is selling its Cytocell fluorescence in situ hybridization products through several affiliates of Sysmex Corp. in Europe. “The move is a testament to the ongoing successful integration of the two companies and commitment to combine efforts to support and serve end users,” according to a press release from OGT.

Read More »

SureSeq NGS analysis software

September 2018—Oxford Gene Technology launched its SureSeq Interpret software, designed to be used with SureSeq NGS panels, to analyze and visualize a range of mutation types and structural variants. The software rapidly processes sequencing data and delivers accurate mutation calling with 100 percent sensitivity and 99.9 percent specificity at >1 percent variant allele frequency.

Read More »

SureSeq NGS analysis software

September 2018—Oxford Gene Technology launched its SureSeq Interpret software, designed to be used with SureSeq NGS panels, to analyze and visualize a range of mutation types and structural variants. The software rapidly processes sequencing data and delivers accurate mutation calling with 100 percent sensitivity and 99.9 percent specificity at >1 percent variant allele frequency.

Read More »

NGS cancer panels, 6/17

June 2017—Oxford Gene Technology has expanded its SureSeq myPanel NGS Custom Cancer Panel content. The expanded content covers more than 70 genes optimized for hematology and solid tumors including breast, colorectal, lung, ovarian and prostate cancer, glioma, melanoma, sarcoma, leukemias, myeloproliferative neoplasms, and myelodysplastic syndrome.

Read More »

FISH probes, 9/16

September 2016—Oxford Gene Technology has expanded its catalog of fluorescence in situ hybridization products with nine Cytocell Aquarius probes: ETV6 Proximal Probe Green, ETV6 Distal Probe Red, MPO Probe Red, TP53 Probe Green, NUP214 Probe Red, DEK Probe Green, TAS2R1 (5p15.31) Probe Green, Chromosome 9 Satellite III Probe Aqua, and Chromosome 15 Alpha Satellite Probe Red.

Read More »
CAP TODAY
X